Switch View
© ACCESSWIRE
28.08.2025
ISIN: CA90468F1027
Unidoc Health Corp.
UDOC
LISTED
CSE
UniDoc Health Corp. Provides Corporate Update
News Preview
VANCOUVER, BC / ACCESS Newswire / August 28, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or "the Company") pleased to provide shareholders with a general corporate update, including an update on its financial filings, corporate activities, and market positioning.Financial statement filing updateUniDoc a...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
28.08.2025
ISIN: US87975F1049
Telomir Pharmaceuticals, Inc.
TELO
LISTED
NASDAQ
Telomir Pharmaceuticals Reports In Vitro Data Supporting the Potential of Telomir-1 as a First-in-Class Epigenetic Therapy Influencing DNA Methylation Pathways in Cancer, Aging, and Age-Related Diseases
News Preview
In vitro findings reveal Telomir-1's dual action: targeting DNA methylation switches and cutting into the Wnt "fuel line" that drives cancer growth. MIAMI, FLORIDA / ACCESS Newswire / August 28, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a preclinical-stage biotechnology company developing therapies that target the root mechanism...
Themefolio
Profiler
Peergroup
© EQS Newswire
28.08.2025
ISIN: CH1243598427
Sandoz Group AG
SDZ
LISTED
XWSX
Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options
News Preview
Sandoz Group AG
/ Key word(s): Product Launch
Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options 28.08.2025 / 07:00 CET/CEST
Media Release
With introduction of 10 mg, 15 mg and 20 mg strengths, Sandoz now provides most comprehensive range of rivaroxaban film-coated tablets......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© ACCESSWIRE
28.08.2025
ISIN: US03209R1032
Amphastar Pharmaceuticals Inc
AMPH
LISTED
NASDAQ
Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference
News Preview
RANCHO CUCAMONGA, CA / ACCESS Newswire / August 28, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, SVP of Corp. Communication, will be participating in an Analyst-Moderated fireside chat at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3rd, 2025, at 12:45 pm ET. For...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
28.08.2025
ISIN: CH0363463438
Idorsia Ltd
IDIA
LISTED
SIX
Idorsia’s TRYVIO – First FDA-approved therapy to target the endothelin pathway for systemic hypertension
News Preview
Allschwil, Switzerland – August 28, 2025Idorsia Ltd (SIX: IDIA) releases an OnDemand investor webcast outlining how TRYVIO™ (aprocitentan) – the first and only hypertension therapy targeting the endothelin pathway – fits into the treatment landscape for difficult-to-control hypertension. In addition, the company will host a live investor Q&A on...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
IBA reports strong Half Year 2025 results, transforming towards a more profitable business
News Preview
Read the entire half year 2025 results press release here...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US1508377066
CEL-SCI Corp
CVM
LISTED
XASE
CEL-SCI Announces Pricing of $10 Million Public Offering
News Preview
CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced the pricing of a best-efforts public offering of 1,111,200 shares of its common stock. Each share of common stock is being sold at a public offering price of $9.00 per share. Total gross proceeds from the offering,...
Themefolio
Profiler
Peergroup
© EQS Newswire
28.08.2025
ISIN: DE000A11QVV0
Heidelberg Pharma AG
HPHA
LISTED
XETR
Heidelberg Pharmas Partner Telix Pharmaceuticals informiert über Stand des Zulassungsantrags für sein Diagnostikum TLX250-CDx
News Preview
Heidelberg Pharmas Partner Telix Pharmaceuticals informiert über Stand des Zulassungsantrags für sein Diagnostikum TLX250-CDx
FDA fordert zusätzliche Daten zum CMC-Paket (Chemistry, Manufacturing and Controls) an
Erwartete Zahlung von 70 Mio. USD von HealthCare Royalty an Heidelberg Pharma wird sich verzögern
Aktuelle Liquiditätsreichweite bis z......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.08.2025
ISIN: DE000A11QVV0
Heidelberg Pharma AG
HPHA
LISTED
XETR
Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250-CDx
News Preview
Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250-CDx
FDA has requested additional data relating to the Chemistry, Manufacturing, and Controls (CMC) package
Expected payment of USD 70 million from HealthCare Royalty to Heidelberg Pharma will be delayed
Current cash reach until Q1 2026
Ladenbu......
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US45258J1025
Immunovant Inc
IMVT
LISTED
NASDAQ
IMVT Investors Have Opportunity to Join Immunovant, Inc. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Immunovant, Inc. (“Immunovant” or “the Company”) (NASDAQ: IMVT) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US19243B1026
Cognition Therapeutics, Inc.
CGTX
LISTED
NASDAQ
Cognition Therapeutics Announces $30 Million Registered Direct Offering of Common Stock
News Preview
- The offering was made to two new fundamental institutional investors -...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US29261A1007
Encompass Health Corp
EHC
LISTED
NYSE
Encompass Health Investor News: Rosen Law Firm Encourages Encompass Health Corporation Investors to Inquire About Securities Class Action Investigation - EHC
News Preview
NEW YORK, Aug. 27, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Encompass Health Corporation (NYSE: EHC) resulting from allegations that Encompass Health may have issued materially misleading business information to the investing...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
27.08.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit First Filed by The Rosen Law Firm
News Preview
NEW YORK, Aug. 27, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclu...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Aug. 27, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i) pursuant and/or traceable to Alto's initial public offering conducted on or about February 2, 2024 (the "IPO"); and/or (ii) securities between February 2, 2024 and October 22, 2...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: AU0000326647
Argent Biopharma Limited
RGT
LISTED
ASX
Argent is Growing Through M&A: Projected Merged Company Value of $100M in AC8 Asset Acquisition
News Preview
Acquisition Expands Clinical Pipeline, Strengthens IP Portfolio, and Grows EU Presence
Highlights
Binding term sheet signed to acquire key assets and IP of AusCann Group Holdings Ltd.
Assets include Neuvis® drug delivery platform, FDA-facing epilepsy pre-clinical data, EU-GMP manufacturing, and German pharma distribution.
Strengthens Argent's cli...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US1508377066
CEL-SCI Corp
CVM
LISTED
XASE
CEL-SCI Announces Proposed Public Offering
News Preview
CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced that it intends to offer to sell shares of its common stock (and/or pre-funded warrants (“Pre-Funded Warrants”) in lieu thereof) in a best-efforts public offering. All of the shares of common stock (and/or Pre-Funde...
Themefolio
Profiler
Peergroup
© Newsfile
27.08.2025
ISIN: US09689V1008
Body and Mind Inc.
BAMM
LISTED
CSE
Correction - Body and Mind Inc. Announces Agreement to Divest from New Jersey
News Preview
Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - August 27, 2025) - Body and Mind Inc. (CSE: BAMM) (OTC: BMMJ) (the "Company" or "BaM") is pleased to announce the Company's wholly owned subsidiary, DEP Nevada, Inc. ("DEP") has entered into a Purchase Agreement with Ascend New Jersey, LLC (the "Purchaser"), whereby DEP, which own...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US89422G1076
Travere Therapeutics Inc
TVTX
LISTED
NASDAQ
Travere Therapeutics Announces U.S. FDA Approves REMS Modification for FILSPARI® (sparsentan) in IgA Nephropathy
News Preview
Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration (FDA) has approved updated Risk Evaluation and Mitigation Strategy (REMS) labeling for FILSPARI® (sparsentan), the only Dual Endothelin Angiotensin Receptor Antagonist for the treatment of IgA nephropathy (IgAN). The update reduces the frequency o...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: IE000LK2BOB4
Mural Oncology PLC
MURA
LISTED
NASDAQ
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Mural Oncology plc (NASDAQ: MURA)
News Preview
NEW YORK, Aug. 27, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building i...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US71742Q1067
Phibro Animal Health Corp
PAHC
LISTED
NASDAQ
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
News Preview
Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2025 and provided its financial guidance for the year ending June 30, 2026.
Highlights for the three months ended June 30, 2025 (compared to the three months ended June 30, 2024)
N...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Bloomberg 500 (B500) Index Adds Sixteen Securities Following Semi-Annual Reconstitution
News Preview
NEW YORK, Aug. 27, 2025 /PRNewswire/ -- Bloomberg Indices announced the following changes to the Bloomberg 500 (B500) Index effective prior to the open of trading on Thursday, September 11, to coincide with the semi-annual reconstitution of the index. The B500 contains the 500 most highly capitalized US companies weighted by float market cap, ref...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: US9139031002
Universal Health Services Inc
UHS
LISTED
NYSE
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT SEPTEMBER HEALTHCARE CONFERENCES
News Preview
KING OF PRUSSIA, Pa., Aug. 27, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the following conferences:
Friday, September 5, 2025, at 10:15am (ET) at the 2025 Wells Fargo Healthcare Conference in Boston, Massachusetts
Wednes...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US40412C1018
HCA Healthcare Inc
HCA
LISTED
NYSE
HCA Healthcare, Inc. to Present at September Healthcare Conference
News Preview
HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conference:
September 4, 2025 at 2:15pm ET at the Wells Fargo 2025 Healthcare Conference.
A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Compa...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Securities Fraud Investigation Into LifeMD, Inc. (LFMD) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON LIFEMD, INC. (LFMD), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YO...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: US5049221055
Labcorp Holdings Inc
LH
LISTED
NYSE
Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
BURLINGTON, N.C., Aug. 27, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, Sept. 9, at 7:45 am ET....
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US03073E1055
Cencora Inc
COR
LISTED
NYSE
Cencora Appoints Mark Durcan as Chairman of Its Board of Directors
News Preview
Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has appointed Lead Independent Director D. Mark Durcan as Chairman of the Board of Directors, effective October 1, 2025. Mr. Durcan will succeed Steven H. Collis, who has served as Cencora’s Chairman since 2016 and previously served as Cencora’s Chief Executive Officer from 2011...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US45337C1027
Incyte Corp
INCY
LISTED
NASDAQ
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Incyte (Nasdaq: INCY) announced today equity inducement awards grants to Soni Basi, the Company’s new Executive Vice President and Chief Human Resources Officer, pursuant to the Company’s 2024 Inducement Stock Incentive Plan. The awards were approved by the compensation committee of the Company’s Board of Directors as an inducement material to the...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: US2681582019
Dynavax Technologies Corp
DVAX
LISTED
NASDAQ
Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference
News Preview
EMERYVILLE, Calif., Aug. 27, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will participate in a fireside chat at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3rd at 4:30 p...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: US4928541048
Kewaunee Scientific Corporation
KEQU
LISTED
NASDAQ
Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2026
News Preview
STATESVILLE, N.C., Aug. 27, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its first quarter fiscal year 2026 financial results on Wednesday, September 10, 2025 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the r...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Veeva Announces Fiscal 2026 Second Quarter Results
News Preview
Total Revenues of $789.1M, up 17% Year Over YearSubscription Services Revenues of $659.2M, up 17% Year Over Year
PLEASANTON, Calif., Aug. 27, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: US88025U1097
10X Genomics Inc
TXG
LISTED
NASDAQ
10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
PLEASANTON, Calif., Aug. 27, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10, at 11:30 a.m. Eastern Time. ...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: IE00B91XRN20
Prothena Corporation PLC
PRTA
LISTED
NASDAQ
Prothena Provides Update on PRX012 and Announces Results from the Phase 1 ASCENT Clinical Program
News Preview
Prothena Corporation plc (NASDAQ:PRTA), today announced results from the Phase 1 ASCENT clinical program in participants with early symptomatic Alzheimer’s disease (AD). As previously communicated, Prothena plans to explore potential partnership interest to advance PRX012 and its preclinical PRX012-TfR (transferrin receptor) antibody.
The Phase...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US30161Q1040
Exelixis Inc
EXEL
LISTED
NASDAQ
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in September
News Preview
Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in fireside chats at the following investor conferences in September:
2025 Wells Fargo Healthcare Conference: Exelixis is scheduled to present at 12:45 p.m. ET / 9:45 a.m. PT on Wednesday, September 3 in Everett, MA.
Citi’s 2025 Biopharma Back to School Co...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US00846U1016
Agilent Technologies Inc
A
LISTED
NYSE
Agilent Reports Third-Quarter Fiscal Year 2025 Financial Results
News Preview
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.74 billion for the third quarter ended July 31, 2025, exceeding revenue guidance and representing growth of 10.1% reported and up 6.1% core(1) compared with the third quarter of 2024.
Third-quarter GAAP net income was $336 million, or $1.18 per share. This compares with $282 millio...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US3741631036
Geron Corp
GERN
LISTED
NASDAQ
Geron to Participate in the 2025 Wells Fargo Healthcare Conference
News Preview
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that management is scheduled to participate in a fireside chat on September 4, 2025 at the 2025 Wells Fargo Healthcare Conference in Boston, MA.
A live webcast of the presentation will be available at ir.geron.com and will be posted on the Investors a...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US67080N1019
Nuvation Bio Inc
NUVB
LISTED
NYSE
Nuvation Bio to Participate in Upcoming Investor Conferences
News Preview
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio, and Philippe Sauvage, Chief Financial Officer of Nuvation Bio, will participate in three upcoming investor confere...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US6047491013
Mirum Pharmaceuticals Inc
TKOMF
LISTED
OTC
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
News Preview
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences:
Citi Biopharma Back-to-School Summit on Wedne...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: CA45783P1027
Innocan Pharma Corporation
INNO
LISTED
CSE
Innocan Pharma Announces First Half Of 2025 Financial Results
News Preview
HERZLIYA, Israel and CALGARY, AB, Aug. 27, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce its financial consolidated results for the six months ended June 30,...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: CA45783P1027
Innocan Pharma Corporation
INNO
LISTED
CSE
Innocan Pharma Announces First Half Of 2025 Financial Results
News Preview
HERZLIYA, Israel and CALGARY, AB, Aug. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce its financial consolidated results for the six months ended Ju...
Themefolio
Profiler
Peergroup
© Newsfile
27.08.2025
ISIN: US68764Y2072
OS Therapies, Inc
OSTX
LISTED
XASE
OS Therapies to Provide OST-HER2 Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma FDA End of Phase 2 Meeting Update on Tuesday, September 2, 2025
News Preview
New York, New York--(Newsfile Corp. - August 27, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced that it will provide stakeholders with a detailed update regarding the Company’s highly constructive Augu...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US71535D1063
Personalis, Inc.
PSNL
LISTED
NASDAQ
Personalis to Participate in Upcoming Investor Conferences
News Preview
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the following conferences:
Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10, 2025, at the Sheraton New York Times Square Hotel in New York, NY
Lake Street 9th Annu...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US98401F1057
Xencor Inc
XNCR
LISTED
NASDAQ
Xencor to Participate at Upcoming Investor Conferences
News Preview
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced that company management will participate at multiple upcoming investor conferences:
2025 Wells Fargo Healthcare Conference
Date: Wednesday, September 3, 2025
Presentation T...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
NUTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Nutex Health Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
NEW YORK, Aug. 27, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or "the Company") (NASDAQ: NUTX) and certain of its officers....
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: US6700021040
Novavax Inc
NVAX
LISTED
NASDAQ
Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.
News Preview
Nuvaxovid™ is the only protein-based, non-mRNA COVID-19 vaccine available in the U.S. for the 2025-2026 vaccination seasonGAITHERSBURG, Md., Aug. 27, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that the U.S. Food and Drug Administration has approved the Nuvaxovid™ 2025-2026 Formula for the prevention of COVID-19 in adults 65...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) and reminds investors of the October 27, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Fa...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Tilray Brands Successfully Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
News Preview
NEW YORK and LEAMINGTON, Ontario, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced that it received written notice from the Nasdaq Stock Market, LLC (“Nasdaq”) co...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US87650L1035
Tarsus Pharmaceuticals Inc
TARS
LISTED
NASDAQ
Tarsus to Participate in Upcoming Investor Conferences
News Preview
IRVINE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US23126K1060
Curanex Pharmaceuticals, Inc.
CURX
LISTED
NASDAQ
Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering
News Preview
Jericho, New York, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) ("Curanex" or the "Company"), a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases, today announced the closing of its initial public offering (the “Offering”) of 3,750,000 shares...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US09627Y1091
Blueprint Medicines Corp
BPMC
LISTED
NASDAQ
Shareholder Alert: The Ademi Firm Investigates the Blueprint Medicines Corporation Transaction
News Preview
The Ademi Firm is investigating Blueprint (Nasdaq: BPMC) and its transaction with Sanofi.
Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you.
In the transaction, Blueprint insiders received substantial benefit...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against LifeMD, Inc. (“LifeMD” or “the Company”) (NASDAQ: LFMD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US4718711033
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
Jasper Therapeutics to Present at Upcoming Investor Conferences
News Preview
REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US2166484020
Cooper Companies Inc
COO
LISTED
NYSE
CooperCompanies Announces Third Quarter 2025 Results
News Preview
SAN RAMON, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: CA39342L1085
Green Thumb Industries Inc
GTII
LISTED
CSE
Green Thumb Industries Announces Brand Transactions with Agrify
News Preview
CHICAGO and VANCOUVER, British Columbia, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announces that it has (i) entered into transactions to sell certain of its consumer pa...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US0327241065
AnaptysBio Inc
ANAB
LISTED
NASDAQ
Anaptys Announces Participation in September Investor Conferences
News Preview
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled to participate in mu...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US8684591089
Supernus Pharmaceuticals Inc
SUPN
LISTED
NASDAQ
Supernus Pharmaceuticals to Participate in September Investor Conferences
News Preview
ROCKVILLE, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today management will participate in the following September investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US0029421007
Aardvark Therapeutics Inc
AARD
LISTED
NASDAQ
Aardvark Therapeutics to Present at Upcoming Investor Conferences in September
News Preview
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, announced that it will present at the following conferences during...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US15102K1007
Celcuity Inc
CELC
LISTED
NASDAQ
Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program
News Preview
MINNEAPOLIS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the U.S. Food and Drug Administration (“FDA”) agreed to accept its New Drug Application (“NDA”) for gedatolisib in HR+/HER2- advanced breast cancer (“ABC”) for...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US68621F1021
Organogenesis Holdings Inc
ORGO
LISTED
NASDAQ
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
News Preview
CANTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the fol...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US79957L1008
Sanara Medtech Inc
SMTI
LISTED
NASDAQ
Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025
News Preview
FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skin markets, tod...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US62855J1043
Myriad Genetics Inc
MYGN
LISTED
NASDAQ
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
News Preview
SALT LAKE CITY, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
